Mankind debuts with #39;outperform#39; rating from Macquarie; stock gets a 30% uptick

Brokerage firm Macquarie Research has given Mankind Pharma Ltd an outperform rating with a target price of Rs 1400 per share, indicating a potential upside of 29.6% from its issue price of Rs 1068 per share.

source https://www.moneycontrol.com/news/buzzing-stocks/mankind-debuts39outperform39-ratingmacquarie-stock-gets30-uptick_16990621.html